Skip to content

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06486506
Acronym
ProFemuRe
Enrollment
150
Registered
2024-07-03
Start date
2024-04-29
Completion date
2025-12-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Tumor, Bone Cancer

Keywords

Proximal Femur Reconstruction, primary bone tumors, imaging

Brief summary

From the archives of the Rizzoli institute all the patients (approximately 150 patients) undergoing oncological reconstruction of proximal femur from 01/01/1991 to 31/12/2023. A review will be made from the medical records, radiological imaging, and histological data of these patients

Interventions

Analysis and review of imaging and clinical data

Sponsors

Costantino Errani
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Male and female patients surgically treated with an oncological reconstruction of the proximal femur at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2023 * Age: 18-90 years old (at the time of primary surgery) * Diagnosis of bone sarcoma * Patients with available clinical and imaging data

Exclusion criteria

* At least one inclusion criterion not met

Design outcomes

Primary

MeasureTime frameDescription
longevity of the reconstructionAt baseline (Day 0)evaluation of the longevity of the reconstruction, meaning reconstruction failure-free survival after surgery

Secondary

MeasureTime frameDescription
Musculoskeletal tumour society (MSTS) functional evaluationat baseline (day 0)The MSTS questionnaire consists of six domains, each scored on a scale from 0 to 5, with a higher score indicating better function.

Countries

Italy

Contacts

Primary ContactCostantino Errani, MD
costantino.errani@ior.it0516366
Backup ContactRoberta Laranga, PhD
roberta.laranga@ior.it051636

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026